181 related articles for article (PubMed ID: 8653663)
1. Prevention and reduction of left ventricular hypertrophy in the elderly.
Lavie CJ; Milani RV; Messerli FH
Clin Geriatr Med; 1996 Feb; 12(1):57-68. PubMed ID: 8653663
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
3. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
Gradman AH; Alfayoumi F
Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular hypertrophy and heart failure in women.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
Ruilope LM; Schmieder RE
Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor.
Messerli FH; Ketelhut R
J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S7-13. PubMed ID: 7507540
[TBL] [Abstract][Full Text] [Related]
7. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
[TBL] [Abstract][Full Text] [Related]
8. Considerations in treating hypertension: focus on risk factors.
Messerli FH
J Hum Hypertens; 1990 Dec; 4 Suppl 5():3-6. PubMed ID: 2151045
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
10. Hypertension and left-ventricular hypertrophy.
Messerli FH; Aepfelbacher FC
Cardiol Clin; 1995 Nov; 13(4):549-57. PubMed ID: 8565018
[TBL] [Abstract][Full Text] [Related]
11. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic implications of left ventricular hypertrophy in arterial hypertension].
Kannel WB
Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():11-21. PubMed ID: 2150470
[TBL] [Abstract][Full Text] [Related]
13. Decrease of left ventricular mass is a clinically valuable intermediate end-point of antihypertensive treatment.
Agabiti-Rosei E
Blood Press Suppl; 1997; 2():13-5. PubMed ID: 9495620
[TBL] [Abstract][Full Text] [Related]
14. Hypertensive heart disease.
Diamond JA; Phillips RA
Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
[TBL] [Abstract][Full Text] [Related]
15. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
[TBL] [Abstract][Full Text] [Related]
16. [Hypertensive cardiopathy. From arterial hypertension to congestive heart failure].
Nogueira JB
Rev Port Cardiol; 1999 Jun; 18(6):635-46. PubMed ID: 10422461
[TBL] [Abstract][Full Text] [Related]
17. Electrocardiographic left ventricular hypertrophy and arterial stiffness: the Ohasama study.
Watabe D; Hashimoto J; Hatanaka R; Hanazawa T; Ohba H; Ohkubo T; Kikuya M; Totsune K; Imai Y
Am J Hypertens; 2006 Dec; 19(12):1199-205. PubMed ID: 17161763
[TBL] [Abstract][Full Text] [Related]
18. Hypertension to heart failure: a pathophysiological spectrum relating blood pressure, drug treatments and stroke.
Subramaniam V; Lip GY
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):703-13. PubMed ID: 19505285
[TBL] [Abstract][Full Text] [Related]
19. [Left ventricular hypertrophy and cardiovascular risk in hypertension].
Amabile G
Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):86-90. PubMed ID: 9772934
[TBL] [Abstract][Full Text] [Related]
20. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
